0001493152-23-001416.txt : 20230113
0001493152-23-001416.hdr.sgml : 20230113
20230113161525
ACCESSION NUMBER: 0001493152-23-001416
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230113
FILED AS OF DATE: 20230113
DATE AS OF CHANGE: 20230113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morse Robert A. Jr.
CENTRAL INDEX KEY: 0001960049
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 23528937
MAIL ADDRESS:
STREET 1: 711 STEWART AVENUE
STREET 2: SUITE 200
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
3
1
ownership.xml
X0206
3
2023-01-13
0
0000868278
ProPhase Labs, Inc.
PRPH
0001960049
Morse Robert A. Jr.
711 STEWART AVENUE, SUITE 200
GARDEN CITY
NY
11530
0
1
0
0
Controller
Stock Option (Right to Buy)
12.01
2029-10-09
Common Stock, par value $0.0005
50000
D
The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.
/s/ Robert A. Morse, Jr.
2023-01-13